Filing Details
- Accession Number:
- 0001209191-17-016207
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-01 20:44:31
- Reporting Period:
- 2017-03-01
- Filing Date:
- 2017-03-01
- Accepted Time:
- 2017-03-01 20:44:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1175505 | Five Prime Therapeutics Inc | FPRX | Pharmaceutical Preparations (2834) | 260038620 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238325 | R William Ringo | Two Corporate Drive South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-03-01 | 500 | $11.65 | 500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-01 | 500 | $46.73 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-03-01 | 500 | $0.00 | 500 | $11.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 21,000 | 2024-09-30 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on April 15, 2016.
- The shares underlying this option vest at a rate of one-third per year on each anniversary of October 1, 2014.
Billionaire Hedge Funds
